The Discounted Cash Flow (DCF) valuation of ACADIA Pharmaceuticals Inc (ACAD) is 29.19 USD. With the latest stock price at 25.60 USD, the upside of ACADIA Pharmaceuticals Inc based on DCF is 14.0%.
Based on the latest price of 25.60 USD and our DCF valuation, ACADIA Pharmaceuticals Inc (ACAD) is a buy. buying Acadia stocks now will result in a potential gain of 14.0%.
| Range | Selected | |
| WACC / Discount Rate | 5.1% - 7.4% | 6.2% |
| Long-term Growth Rate | 3.0% - 4.9% | 3.9% |
| Fair Price | 16.73 - 246.23 | 29.19 |
| Upside | -34.6% - 861.8% | 14.0% |